BridgeMD
New treatment option for Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Official title Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
ClinicalTrials.gov ID: NCT06777420
What this study is testing
- What it's testing
- Preoperative chemotherapy has been shown to be at least as effective as postoperative chemotherapy in breast cancer patients and has seen increased use over time. The decision regarding neoadjuvant treatment is complex, as various aspects need to be considered, and the patient's role in the decision-making process is central.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Patients with operable breast cancer eligible for systemic neoadjuvant therapy, according to current treatment guidelines.
You likely can't join if
- Patients with locally advanced breast cancer where neoadjuvant therapy is mandatory rather than a treatment option.
- Patients with cognitive impairment that are assessed from treating physician as unable to participate.
- Patients who cannot speak/read neither Swedish nor English.
The study team makes the final eligibility decision.
Where it's taking place
- Uppsala, Region Uppsala, Sweden
- Västerås, Region Västmanland, Sweden
- Örebro, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uppsala, Region Uppsala, Sweden; Västerås, Region Västmanland, Sweden; Örebro, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.